BR9909996B1 - composto derivado de imidazo piridina, processo para a preparaÇço de um composto, formulaÇço farmacÊutica, e, uso de um composto. - Google Patents

composto derivado de imidazo piridina, processo para a preparaÇço de um composto, formulaÇço farmacÊutica, e, uso de um composto.

Info

Publication number: BR9909996B1
Authority: BR; Brazil
Prior art keywords: compound; preparation; pharmaceutical formulation; pyridine derivative; imidazo pyridine
Prior art date: 1998-04-29

Application number

BRPI9909996-9A

Other languages

English (en)

Other versions

BR9909996A (pt

Inventor

Kosrat Amin

Michael Dahlstroem

Peter Nordberg

Ingemar Starke

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-29

Filing date

1999-04-23

Publication date

2010-08-24

1999-04-23 Application filed filed Critical

2000-12-26 Publication of BR9909996A publication Critical patent/BR9909996A/pt

2010-08-24 Publication of BR9909996B1 publication Critical patent/BR9909996B1/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

BRPI9909996-9A 1998-04-29 1999-04-23 composto derivado de imidazo piridina, processo para a preparaÇço de um composto, formulaÇço farmacÊutica, e, uso de um composto. BR9909996B1 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9801526A SE9801526D0 (sv)	1998-04-29	1998-04-29	New compounds
PCT/SE1999/000663 WO1999055706A1 (en)	1998-04-29	1999-04-23	Imidazo pyridine derivatives which inhibit gastric acid secretion

Publications (2)

Publication Number	Publication Date
BR9909996A BR9909996A (pt)	2000-12-26
BR9909996B1 true BR9909996B1 (pt)	2010-08-24

Family

ID=20411154

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
BRPI9909995-0A BR9909995B1 (pt)	1998-04-29	1999-04-23	composto, processo para a preparação de um composto, formulação farmacêutica, e, uso de um composto.
BRPI9909996-9A BR9909996B1 (pt)	1998-04-29	1999-04-23	composto derivado de imidazo piridina, processo para a preparaÇço de um composto, formulaÇço farmacÊutica, e, uso de um composto.

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
BRPI9909995-0A BR9909995B1 (pt)	1998-04-29	1999-04-23	composto, processo para a preparação de um composto, formulação farmacêutica, e, uso de um composto.

Country Status (34)

Country	Link
US (2)	US6313137B1 (pt)
EP (4)	EP1491543B1 (pt)
JP (2)	JP3883383B2 (pt)
KR (3)	KR100595806B1 (pt)
CN (2)	CN1165535C (pt)
AR (2)	AR015768A1 (pt)
AT (4)	ATE312101T1 (pt)
AU (2)	AU769190B2 (pt)
BR (2)	BR9909995B1 (pt)
CA (2)	CA2329922C (pt)
CZ (2)	CZ292567B6 (pt)
DE (4)	DE69937076T2 (pt)
DK (2)	DK1073657T3 (pt)
EE (2)	EE04676B1 (pt)
ES (2)	ES2252975T3 (pt)
HK (5)	HK1033457A1 (pt)
HU (2)	HUP0102425A3 (pt)
ID (2)	ID27530A (pt)
IL (4)	IL139200A0 (pt)
IS (2)	IS5684A (pt)
MY (2)	MY121379A (pt)
NO (2)	NO318203B1 (pt)
NZ (2)	NZ507639A (pt)
PL (2)	PL195000B1 (pt)
RU (2)	RU2235725C2 (pt)
SA (2)	SA99200065B1 (pt)
SE (1)	SE9801526D0 (pt)
SI (1)	SI1073656T1 (pt)
SK (2)	SK285768B6 (pt)
TR (4)	TR200003176T2 (pt)
TW (2)	TW490466B (pt)
UA (2)	UA67769C2 (pt)
WO (2)	WO1999055706A1 (pt)
ZA (2)	ZA200005796B (pt)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US6489346B1 (en)	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
SE9802794D0 (sv) *	1998-08-21	1998-08-21	Astra Ab	New compounds
SE0003186D0 (sv) *	2000-09-07	2000-09-07	Astrazeneca Ab	New process
US6900324B2 (en)	2000-09-07	2005-05-31	Astrazeneca Ab	Process for preparing a substituted imidazopyridine compound
UA80393C2 (uk)	2000-12-07	2007-09-25	Алтана Фарма Аг	Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0100295D0 (sv) *	2001-02-01	2001-02-01	Astrazeneca Ab	New compounds
SE0100296D0 (sv) *	2001-02-01	2001-02-01	Astrazeneca Ab	New compounds
SE0100297D0 (sv) *	2001-02-01	2001-02-01	Astrazeneca Ab	New compounds
CA2434835A1 (en) *	2001-02-13	2002-08-22	Astrazeneca Ab	Novel modified released formulation
EE05234B1 (et) *	2001-03-08	2009-12-15	Astrazeneca Ab	6-karboksamidoimidaso[1,2-a] pridiinihendite kasutamine ravimi p?hjustatud maohaavandi vltimiseks
SE0102808D0 (sv) *	2001-08-22	2001-08-22	Astrazeneca Ab	New compounds
MY140561A (en) *	2002-02-20	2009-12-31	Nycomed Gmbh	Dosage form containing pde 4 inhibitor as active ingredient
SE0201939D0 (sv) *	2002-06-20	2002-06-20	Astrazeneca Ab	New combination
SE0201940D0 (sv) *	2002-06-20	2002-06-20	Astrazeneca Ab	New combination II
NZ538566A (en)	2002-09-19	2008-02-29	Schering Corp	Imidazopyridines as cyclin dependent kinase inhibitors
CN100384842C (zh)	2002-11-19	2008-04-30	奥坦纳医药公司	8-取代的咪唑并吡啶类化合物
AR043002A1 (es) *	2003-02-18	2005-07-13	Altana Pharma Ag	Imidazopirazinas 6-substituidos
AP2114A (en) *	2003-02-26	2010-03-04	Sugen Inc	Aminoheteroaryl compounds as protein kinase inhibitors
DE602004023921D1 (de)	2003-03-10	2009-12-17	Nycomed Gmbh	Neues verfahren zur herstellung vonroflumilast
SE525349C2 (sv) *	2003-06-23	2005-02-08	Volvo Penta Ab	Utombordsdrev för båtar
SE0301905D0 (sv) *	2003-06-26	2003-06-26	Astrazeneca Ab	Novel imidazopyridine compound I with therapeutic effect
SE0301904D0 (sv) *	2003-06-26	2003-06-26	Astrazeneca Ab	Novel imidazopyridine compound II with therapeutic effect
SE0301903D0 (sv) *	2003-06-26	2003-06-26	Astrazeneca Ab	Novel imidazopyridine compound III with therapeutic effect
US8993599B2 (en)	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AU2004285394B2 (en) *	2003-11-03	2009-01-08	Astrazeneca Ab	Imidazo (1,2-A) pyridine derivatives for the treatment of silent gastro-esophageal reflux
SE0303451D0 (sv) *	2003-12-18	2003-12-18	Astrazeneca Ab	New compounds
EP1711498A2 (en) *	2004-01-26	2006-10-18	Altana Pharma AG	1,2,4-triazolo¬1,5-a\|pyridines as gastric acid secretion inhibitors
US8906940B2 (en)	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AP2007004023A0 (en) *	2004-12-17	2007-06-30	Pfizer	Chromane derivatives useful as acid pump antagonists
AU2006224619B2 (en)	2005-03-16	2012-06-07	Takeda Gmbh	Taste masked dosage form containing roflumilast
ES2470766T3 (es) *	2005-03-21	2014-06-24	Mei Pharma, Inc.	Derivados de [1,2-a]piridina: preparación y aplicaciones farmacéuticas
US7666880B2 (en)	2005-03-21	2010-02-23	S*Bio Pte Ltd.	Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
TW200700064A (en) *	2005-03-24	2007-01-01	Glaxo Group Ltd	Novel compounds
GB0513423D0 (en) *	2005-06-30	2005-08-03	Glaxo Group Ltd	Novel compounds
KR101146852B1 (ko) *	2005-12-05	2012-05-16	화이자 프로덕츠 인크.	Ｃ?ｍｅｔ／ｈｇｆｒ 억제제의 다형체
BRPI0619424B1 (pt) *	2005-12-05	2022-02-08	Pfizer Products Inc	Uso de inibidores c-met/hgfrs para a fabricação de medicamentos
WO2007107827A1 (en) *	2006-03-17	2007-09-27	Raqualia Pharma Inc.	Chromane derivatives
EP2054036B1 (en)	2006-07-24	2019-12-18	Singh-Broemer and Company, Inc.	Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
WO2008059373A1 (en) *	2006-11-17	2008-05-22	Raqualia Pharma Inc.	Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
EP1974729A1 (en) *	2007-03-28	2008-10-01	Santhera Pharmaceuticals (Schweiz) AG	Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists
US8513226B2 (en) *	2008-03-31	2013-08-20	Council Of Scientific And Industrial Research	Simultaneous method for the preparation of a mixture of 3-acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3-acetoxy-2'-chloro-5-androsteno[17,16-b]pyridine
AU2014201644B2 (en) *	2008-12-03	2015-05-21	Cinclus Pharma Holding AB (publ)	Imidazopyridine derivatives which inhibit the secretion of gastric acid
FI20086158A0 (fi)	2008-12-03	2008-12-03	Mikael Dahlstroem	Imidatsopyridiinijohdannaiset
CN105919998B (zh)	2009-07-09	2021-08-24	拉夸里亚创药株式会社	用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂
BR112015030288B1 (pt) *	2013-06-25	2022-10-18	Ptc Therapeutics, Inc.	Compostos e seu uso no tratamento de atrofia muscular espinhal
US9944637B2 (en)	2013-12-16	2018-04-17	Asana Biosciences, Llc	P2X3 and/or P2X2/3 compounds and methods
JP6578298B2 (ja) *	2014-03-24	2019-09-18	アークルインコーポレイテッド	３−（３−（４−（１−アミノシクロブチル）フェニル）−５−フェニル−３ｈ−イミダゾ［４，５−ｂ］ピリジン−２−イル）ピリジン−２−アミンを調製する方法
CN106279151A (zh) *	2015-06-26	2017-01-04	江苏太瑞生诺生物医药科技有限公司	5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法
KR101777971B1 (ko) *	2016-07-05	2017-09-12	제일약품주식회사	이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도
KR20190057569A (ko)	2017-11-20	2019-05-29	제일약품주식회사	7-아미노-1h-인돌-5-카르복사미드 유도체 및 이의 용도
CN111683976B (zh)	2018-02-05	2022-11-18	生物辐射实验室股份有限公司	具有阴离子交换-疏水混合模式配体的色谱树脂
WO2019197232A1 (de) *	2018-04-10	2019-10-17	Bayer Aktiengesellschaft	Verfahren zur herstellung von 2,6-dialkylphenyl-essigsäuren
RU2732297C2 (ru) *	2018-11-14	2020-09-15	Общество с ограниченной ответственностью "Гурус БиоФарм"	Производные нестероидных противовоспалительных средств
CA3156073A1 (en)	2019-11-04	2021-05-14	Cinclus Pharma Holding AB	Oral formulation of x842
CA3235361A1 (en)	2021-11-05	2023-05-11	Kjell JARRING	Polymorphs of the hydrochloride salt of linaprazan glurate
CN118414334A (zh)	2021-11-05	2024-07-30	辛克鲁斯制药控股有限公司（Publ）	谷氨酸利那拉生甲磺酸盐的多晶型物
KR102496869B1 (ko) *	2022-07-29	2023-02-07	제일약품주식회사	이미다조[1,2-a]피리딘 화합물의 신규 염, 이의 결정형 및 제조방법
WO2024149834A1 (en)	2023-01-11	2024-07-18	Cinclus Pharma Holding AB (publ)	Polymorphs of the hydrobromide salt of linaprazan glurate
WO2024149833A1 (en)	2023-01-11	2024-07-18	Cinclus Pharma Holding AB (publ)	Polymorphs of the maleic acid salt of linaprazan glurate
WO2024161317A1 (ko) *	2023-02-01	2024-08-08	제일약품주식회사	약학적 제제, 이의 제조 방법, 및 정제용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA81219B (en) *	1980-01-23	1982-01-27	Schering Corp	Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en)	1981-06-26	1986-03-05	Schering Corporation	Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) *	1985-06-04	1988-02-16	Fujisawa Pharmaceutical Co., Ltd.	Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) *	1985-12-16	1987-07-08	Fujisawa Pharmaceutical Co., Ltd.	Imidazopyridine compounds and processes for preparation thereof
GB8722488D0 (en)	1987-09-24	1987-10-28	Fujisawa Pharmaceutical Co	Imidazopyridine compound

1998
- 1998-04-29 SE SE9801526A patent/SE9801526D0/xx unknown
1999
- 1999-04-16 TW TW088106129A patent/TW490466B/zh not_active IP Right Cessation
- 1999-04-16 AR ARP990101776A patent/AR015768A1/es active IP Right Grant
- 1999-04-16 AR ARP990101777A patent/AR015769A1/es active IP Right Grant
- 1999-04-16 TW TW088106128A patent/TWI250159B/zh not_active IP Right Cessation
- 1999-04-23 PL PL343801A patent/PL195000B1/pl not_active IP Right Cessation
- 1999-04-23 AU AU43007/99A patent/AU769190B2/en not_active Ceased
- 1999-04-23 EP EP04023091A patent/EP1491543B1/en not_active Expired - Lifetime
- 1999-04-23 ES ES99947038T patent/ES2252975T3/es not_active Expired - Lifetime
- 1999-04-23 BR BRPI9909995-0A patent/BR9909995B1/pt not_active IP Right Cessation
- 1999-04-23 CA CA002329922A patent/CA2329922C/en not_active Expired - Fee Related
- 1999-04-23 EP EP99947037A patent/EP1073656B1/en not_active Expired - Lifetime
- 1999-04-23 WO PCT/SE1999/000663 patent/WO1999055706A1/en not_active Application Discontinuation
- 1999-04-23 JP JP2000545864A patent/JP3883383B2/ja not_active Expired - Fee Related
- 1999-04-23 EP EP99947038A patent/EP1073657B1/en not_active Expired - Lifetime
- 1999-04-23 CA CA002329921A patent/CA2329921A1/en not_active Abandoned
- 1999-04-23 IL IL13920099A patent/IL139200A0/xx unknown
- 1999-04-23 TR TR2000/03176T patent/TR200003176T2/xx unknown
- 1999-04-23 HU HU0102425A patent/HUP0102425A3/hu unknown
- 1999-04-23 EE EEP200000626A patent/EE04676B1/xx not_active IP Right Cessation
- 1999-04-23 IL IL13929799A patent/IL139297A0/xx active IP Right Grant
- 1999-04-23 UA UA2000106033A patent/UA67769C2/uk unknown
- 1999-04-23 CZ CZ20003982A patent/CZ292567B6/cs not_active IP Right Cessation
- 1999-04-23 CZ CZ20003981A patent/CZ293977B6/cs not_active IP Right Cessation
- 1999-04-23 SK SK1492-2000A patent/SK285768B6/sk not_active IP Right Cessation
- 1999-04-23 WO PCT/SE1999/000662 patent/WO1999055705A1/en not_active Application Discontinuation
- 1999-04-23 TR TR2001/02612T patent/TR200102612T2/xx unknown
- 1999-04-23 HU HU0102313A patent/HUP0102313A3/hu unknown
- 1999-04-23 DK DK99947038T patent/DK1073657T3/da active
- 1999-04-23 DE DE69937076T patent/DE69937076T2/de not_active Expired - Lifetime
- 1999-04-23 SI SI9930850T patent/SI1073656T1/sl unknown
- 1999-04-23 AT AT99947038T patent/ATE312101T1/de not_active IP Right Cessation
- 1999-04-23 BR BRPI9909996-9A patent/BR9909996B1/pt not_active IP Right Cessation
- 1999-04-23 US US09/319,973 patent/US6313137B1/en not_active Expired - Fee Related
- 1999-04-23 UA UA2000106034A patent/UA66846C2/uk unknown
- 1999-04-23 NZ NZ507639A patent/NZ507639A/en unknown
- 1999-04-23 JP JP2000545865A patent/JP3692034B2/ja not_active Expired - Fee Related
- 1999-04-23 TR TR2000/03149T patent/TR200003149T2/xx unknown
- 1999-04-23 RU RU2000127020/04A patent/RU2235725C2/ru active
- 1999-04-23 EP EP04023090A patent/EP1491542B1/en not_active Expired - Lifetime
- 1999-04-23 ID IDW20002205A patent/ID27530A/id unknown
- 1999-04-23 SK SK1491-2000A patent/SK14912000A3/sk unknown
- 1999-04-23 TR TR2001/02728T patent/TR200102728T2/xx unknown
- 1999-04-23 AT AT99947037T patent/ATE307130T1/de not_active IP Right Cessation
- 1999-04-23 CN CNB998078026A patent/CN1165535C/zh not_active Expired - Fee Related
- 1999-04-23 AT AT04023091T patent/ATE372340T1/de not_active IP Right Cessation
- 1999-04-23 DE DE69928792T patent/DE69928792T2/de not_active Expired - Lifetime
- 1999-04-23 CN CNB998077992A patent/CN1174980C/zh not_active Expired - Fee Related
- 1999-04-23 ID IDW20002206A patent/ID26819A/id unknown
- 1999-04-23 NZ NZ507638A patent/NZ507638A/en unknown
- 1999-04-23 KR KR1020007012027A patent/KR100595806B1/ko not_active IP Right Cessation
- 1999-04-23 AT AT04023090T patent/ATE372339T1/de not_active IP Right Cessation
- 1999-04-23 EE EEP200000664A patent/EE04916B1/xx not_active IP Right Cessation
- 1999-04-23 KR KR1020007012028A patent/KR100650472B1/ko not_active IP Right Cessation
- 1999-04-23 DK DK99947037T patent/DK1073656T3/da active
- 1999-04-23 ES ES99947037T patent/ES2249913T3/es not_active Expired - Lifetime
- 1999-04-23 DE DE69937077T patent/DE69937077T2/de not_active Expired - Lifetime
- 1999-04-23 PL PL99343797A patent/PL343797A1/xx unknown
- 1999-04-23 US US09/319,890 patent/US6313136B1/en not_active Expired - Fee Related
- 1999-04-23 RU RU2000127019/04A patent/RU2238271C2/ru active
- 1999-04-23 KR KR1020057022787A patent/KR100595805B1/ko not_active IP Right Cessation
- 1999-04-23 AU AU43006/99A patent/AU769108B2/en not_active Ceased
- 1999-04-23 DE DE69927803T patent/DE69927803T2/de not_active Expired - Lifetime
- 1999-04-27 MY MYPI99001650A patent/MY121379A/en unknown
- 1999-04-27 MY MYPI99001649A patent/MY121389A/en unknown
- 1999-05-01 SA SA99200065A patent/SA99200065B1/ar unknown
- 1999-05-01 SA SA99200064A patent/SA99200064B1/ar unknown
2000
- 2000-10-18 ZA ZA200005796A patent/ZA200005796B/en unknown
- 2000-10-18 ZA ZA200005797A patent/ZA200005797B/en unknown
- 2000-10-23 IL IL139200A patent/IL139200A/en not_active IP Right Cessation
- 2000-10-25 IS IS5684A patent/IS5684A/is unknown
- 2000-10-25 IS IS5683A patent/IS5683A/is unknown
- 2000-10-26 IL IL139297A patent/IL139297A/en not_active IP Right Cessation
- 2000-10-27 NO NO20005451A patent/NO318203B1/no not_active IP Right Cessation
- 2000-10-27 NO NO20005450A patent/NO317262B1/no not_active IP Right Cessation
2001
- 2001-06-12 HK HK01104026A patent/HK1033457A1/xx not_active IP Right Cessation
- 2001-06-13 HK HK01104064A patent/HK1033317A1/xx not_active IP Right Cessation
- 2001-06-13 HK HK05103978A patent/HK1071139A1/xx not_active IP Right Cessation
- 2001-11-07 HK HK01107808A patent/HK1036981A1/xx not_active IP Right Cessation
- 2001-11-08 HK HK01107857A patent/HK1036984A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
EE04676B1 (et)	2006-08-15
IL139297A0 (en)	2001-11-25
BR9909995A (pt)	2000-12-26
ATE372340T1 (de)	2007-09-15
NO317262B1 (no)	2004-09-27
EE04916B1 (et)	2007-10-15
DK1073657T3 (da)	2006-03-13
CN1307577A (zh)	2001-08-08
IS5683A (is)	2000-10-25
IL139200A0 (en)	2001-11-25
JP3692034B2 (ja)	2005-09-07
TR200003176T2 (tr)	2001-03-21
PL343801A1 (en)	2001-09-10
KR100650472B1 (ko)	2006-11-28
ZA200005796B (en)	2002-01-18
DE69927803T2 (de)	2006-07-06
NZ507638A (en)	2003-10-31
JP2002513024A (ja)	2002-05-08
NO20005450D0 (no)	2000-10-27
WO1999055706A9 (en)	2000-03-16
CN1165535C (zh)	2004-09-08
DE69928792T2 (de)	2006-07-20
DE69937077D1 (de)	2007-10-18
MY121389A (en)	2006-01-28
ID26819A (id)	2001-02-15
CZ20003982A3 (cs)	2001-02-14
ES2249913T3 (es)	2006-04-01
SK285768B6 (sk)	2007-07-06
IL139297A (en)	2007-06-03
AU4300699A (en)	1999-11-16
US6313136B1 (en)	2001-11-06
AU4300799A (en)	1999-11-16
HK1033317A1 (en)	2001-08-24
DE69937077T2 (de)	2008-05-29
SK14912000A3 (sk)	2001-06-11
CA2329922A1 (en)	1999-11-04
SA99200064B1 (ar)	2006-10-11
ATE307130T1 (de)	2005-11-15
CZ292567B6 (cs)	2003-10-15
SI1073656T1 (sl)	2006-02-28
WO1999055706A1 (en)	1999-11-04
EP1491542A3 (en)	2005-01-05
HK1071139A1 (en)	2005-07-08
IS5684A (is)	2000-10-25
KR20010043133A (ko)	2001-05-25
ES2252975T3 (es)	2006-05-16
PL343797A1 (en)	2001-09-10
MY121379A (en)	2006-01-28
JP2002513025A (ja)	2002-05-08
UA66846C2 (uk)	2004-06-15
UA67769C2 (uk)	2004-07-15
CA2329921A1 (en)	1999-11-04
NO20005451L (no)	2000-12-27
AR015769A1 (es)	2001-05-16
DK1073656T3 (da)	2006-01-16
EE200000626A (et)	2002-04-15
US6313137B1 (en)	2001-11-06
RU2238271C2 (ru)	2004-10-20
EP1491542A2 (en)	2004-12-29
CZ20003981A3 (cs)	2001-03-14
DE69937076D1 (de)	2007-10-18
HUP0102313A3 (en)	2002-10-28
ATE372339T1 (de)	2007-09-15
AU769190B2 (en)	2004-01-22
SK14922000A3 (sk)	2001-06-11
KR20010043134A (ko)	2001-05-25
KR100595806B1 (ko)	2006-07-03
BR9909995B1 (pt)	2010-07-13
DE69927803D1 (de)	2006-03-02
NZ507639A (en)	2004-01-30
PL195000B1 (pl)	2007-07-31
EP1073656A1 (en)	2001-02-07
ID27530A (id)	2001-04-12
SA99200065A (ar)	2005-12-03
BR9909996A (pt)	2000-12-26
TR200102612T2 (tr)	2002-06-21
HK1036981A1 (en)	2002-01-25
JP3883383B2 (ja)	2007-02-21
TR200102728T2 (tr)	2002-06-21
TWI250159B (en)	2006-03-01
EP1073656B1 (en)	2005-10-19
SA99200065B1 (ar)	2006-11-07
WO1999055705A1 (en)	1999-11-04
HUP0102313A2 (hu)	2001-12-28
EP1491543B1 (en)	2007-09-05
IL139200A (en)	2010-04-29
SE9801526D0 (sv)	1998-04-29
ZA200005797B (en)	2002-01-18
TR200003149T2 (tr)	2001-03-21
CZ293977B6 (cs)	2004-09-15
TW490466B (en)	2002-06-11
KR100595805B1 (ko)	2006-07-03
HUP0102425A3 (en)	2002-12-28
DE69928792D1 (de)	2006-01-12
HK1036984A1 (en)	2002-01-25
EE200000664A (et)	2002-04-15
EP1491542B1 (en)	2007-09-05
HUP0102425A2 (hu)	2001-11-28
EP1073657A1 (en)	2001-02-07
AR015768A1 (es)	2001-05-16
EP1491543A1 (en)	2004-12-29
NO20005450L (no)	2000-12-22
EP1073657B1 (en)	2005-12-07
DE69937076T2 (de)	2008-05-29
CA2329922C (en)	2006-04-11
NO318203B1 (no)	2005-02-14
CN1306533A (zh)	2001-08-01
HK1033457A1 (en)	2001-08-31
RU2235725C2 (ru)	2004-09-10
KR20050121760A (ko)	2005-12-27
NO20005451D0 (no)	2000-10-27
ATE312101T1 (de)	2005-12-15
CN1174980C (zh)	2004-11-10
AU769108B2 (en)	2004-01-15

Publication	Publication Date	Title
BR9909996B1 (pt)	2010-08-24	composto derivado de imidazo piridina, processo para a preparaÇço de um composto, formulaÇço farmacÊutica, e, uso de um composto.
BR9912109B1 (pt)	2012-08-21	compostos derivados de quinolina, composições farmacêuticas, processo para a manufatura de um composto, e, uso de um composto.
BR9808422B1 (pt)	2010-08-24	composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
BR9810802B1 (pt)	2010-10-19	composto, composição farmacêutica, e, processo para a preparação de um composto.
BR9806870B1 (pt)	2009-05-05	composto amidino, formulação farmacêutica, uso de um composto, e, processo papa preparar o mesmo.
BR9810829B1 (pt)	2009-08-11	composto heterocìclico, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica.
BR9501770A (pt)	1995-11-21	Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto
BR9801606B1 (pt)	2010-07-27	composto, processo para sua preparação, substáncia farmacêutica, uso do composto e processo para a produção de uma substáncia farmacêutica.
EE200200095A (et)	2003-04-15	Sulfonüülkarboksamiidi derivaadid, nende kasutamine, ravim ja nende valmistamismeetod
NO986023L (no)	1999-02-15	Vannbasert, farmas°ytisk preparat
BR0009083B1 (pt)	2011-11-01	derivado de amida compreendendo um núcleo de quinazolinona, processo para a preparação de um derivado de amida, composição farmacêutica, e, uso de um derivado de amida.
BR9909925B1 (pt)	2010-09-21	derivados de quinolina, composições farmacêuticas, e, processo para a fabricação de derivados de quinolina.
EE04721B1 (et)	2006-10-16	Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine
FI964395A (fi)	1996-10-31	Uudet erytromysiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
BR9711311B1 (pt)	2009-01-13	derivado de 1,2,3,4-tetrahidroquinolina, composiÇço farmaceutica, uso de um derivado de 1,2,3,4-tetrahidroquinolina, e, processo para a preparaÇço de compostos.
BR9912104B1 (pt)	2010-07-13	compostos derivados de quinolina, composições farmacêuticas, e, processo para a manufatura de um composto.
BR9404809A (pt)	1995-08-01	Composto, uso, formulação farmacêutica e processo para preparar um composto
BR9803720B1 (pt)	2009-05-05	composto de pigmento de quinoxalina-monoazo-acetarilida, processo para a preparação e uso do mesmo.
EE04151B1 (et)	2003-10-15	Atsüülpiperasinüülpürimidiinide derivaadid, nendevalmistamine ja kasutamine ravimitena
EE9800265A (et)	1999-02-15	Erütromütsiini derivaadid, nende valmistamismeetod ja kasutamine ravimitena
PT1165081E (pt)	2005-08-31	Processo para a preparacao de preparacoes farmaceuticas cintendo tolperisona, para administracao oral
EE9900112A (et)	1999-10-15	2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
BR9807682B1 (pt)	2009-01-13	composto, uso do mesmo, composiÇço farmacÊutica, e, processos para preparar um composto.
EE04346B1 (et)	2004-08-16	Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
BR9602025A (pt)	1998-10-06	Composto composição farmacêutica uso e processo para a preparação de um composto

Legal Events

Date	Code	Title	Description
2008-04-22	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2008-10-28	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2009-03-31	B11B	Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
2009-05-19	B11N	Dismissal: publication cancelled [chapter 11.14 patent gazette]	Free format text: REFERENTE A RPI 1995 DE 31/03/2009.
2009-12-15	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2010-08-24	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/08/2010, OBSERVADAS AS CONDICOES LEGAIS.
2012-11-13	B24C	Patent annual fee: request for for restoration	Free format text: REFERENTE A 12A E 13A ANUIDADE.
2015-12-01	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE AS 12A, 13A, 14A, 15A E 16A ANUIDADES. PAGAR RESTAURACAO.
2016-03-29	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.